Cargando…
Dengue vaccine development: status and future
Dengue, the most common arbovirus, represents an increasingly significant cause of morbidity worldwide, including in travelers. After decades of research, the first dengue vaccine was licensed in 2015: CYD-TDV, a tetravalent live attenuated vaccine with a yellow fever vaccine backbone. Recent analys...
Autor principal: | Wilder-Smith, Annelies |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224137/ https://www.ncbi.nlm.nih.gov/pubmed/31784763 http://dx.doi.org/10.1007/s00103-019-03060-3 |
Ejemplares similares
-
Dengue vaccine development by the year 2020: challenges and prospects
por: Wilder-Smith, Annelies
Publicado: (2020) -
Dengue: Challenges for Policy Makers and Vaccine Developers
por: Wilder-Smith, Annelies, et al.
Publicado: (2014) -
Developing vaccines against epidemic-prone emerging infectious diseases
por: Bernasconi, Valentina, et al.
Publicado: (2019) -
Medical drones: Disruptive technology makes the future happen
por: Sigari, Cyrus, et al.
Publicado: (2021) -
Versorgungsstrukturen in der ambulanten Pädiatrie: Status quo und Ausblick
por: Voitl, Peter
Publicado: (2022)